A New Tactic is being used by Republican Party

Republicans have come up with a new tactic involving the pharmaceutical industry's advertising and pricing, aiming to address concerns surrounding high drug costs and the influence of advertising on consumer choices.

This strategy focuses on scrutinizing the ways in which pharmaceutical companies market their products, particularly the extensive advertising campaigns that often promote brand-name drugs while overshadowing more affordable generic alternatives.

Republican lawmakers are seeking to foster a more competitive marketplace that could lead to lower prices for consumers at the same time persuade the voting public they are in their corner and are working to help the average working man.

In addition to examining advertising practices, this new approach also emphasizes the need for transparency in drug pricing. Republicans are advocating for policies that would require pharmaceutical companies to disclose the actual costs of drug development and the pricing structures that lead to exorbitant retail prices.

By doing this, they hope to empower consumers with the knowledge necessary to make informed decisions about their healthcare options, potentially leading to increased pressure on pharmaceutical companies to justify their pricing strategies.

Furthermore, this tactic may involve collaborating with various stakeholders, including healthcare providers, and insurers to create a framework aimed at reducing drug costs.

Ultimately, this approach represents a significant shift in how Republicans are engaging with the issue of pharmaceutical pricing and recognition of the need for reform in a sector that has long been criticized for its lack of accountability and transparency.

By leveraging these tactics, they aim to resonate with voters who are increasingly concerned about healthcare affordability and the rising costs of prescription medications.

Where have the Democrats been on this subject? For years they have been giving us lip service to this issue and it makes everyone wonder who is in the pocket of the drug industry.

The drug industry spends on average over 10 billion dollars a year on advertising, with profits exceeding 15% to 20%, where most companies feel lucky to achieve 5% to 10% in profits. The Republicans are going to be asking the same question everyone who watches a television asks, why are you spending so much money on advertising, when your drug prices are so high.

Direct to consumer advertising although it was never illegal, was not done heavily until the 1990's when rules on advertising practices were relaxed. This is going to be one of the many questions lawmakers in the Republican Party will be asking drug makers. Now we will see who is benefitting from the drug lobby.

Where is Hakeem Jeffries? Does he know how to build a following on a hot topic? Again, the Democratic Party does not have clue what is happening on main street in America? There are many things wrong, but you cannot bounce from one problem to the next and not stay focused on one or two things. Pick something and stay with it.

Jack Wilson

Opinion